common.study.topics.clinical

Testing Experimental Medication in Healthy Subjects

common.study.values.description

A Study of LY3556050 in Healthy Participants

The main purpose of this study is to learn more about the safety of LY3556050 after it is given by mouth to healthy participants. Blood tests will be performed to check how much LY3556050 gets into the bloodstream and how long the body takes to get rid of it. Each enrolled participant will receive multiple doses of LY3556050 or placebo and will remain in the study for up to 31 days.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - LY3556050

Administered orally.

Drug - Placebo

Administered orally.

Drug - Iohexol

Administered IV.

Drug - Metformin

Administered orally.

participant.views.study.view.additional

participant.views.study.view.scientific-title

Multiple-Ascending Dose, Safety, Tolerability, and Pharmacokinetic Study With LY3556050 in Healthy Subjects

common.study.values.clinical-trial-id

NCT04156750

participant.views.study.view.id

aM843e